drugset / Trial / NCT04558112

Improving Therapeutic Learning for PTSD

NCT04558112

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The proposed project seeks to demonstrate the engagement of post-exposure dopamine neurotransmission and downstream acute reorganization of dopaminergic resting-state neural networks as a means of increasing consolidation of extinction memories formed during analogue exposure therapy in adult women with PTSD. Participants will include 120 women aged 21-50 with a current diagnosis of PTSD related to physical or sexual assault, English speaking, and medically healthy. Participants will complete the stages of the study across 2-3 days, depending on participant need.

Timeline

Start
2021-02-18
Primary completion
2023-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule 100 mg Oral
Background Carbidopa Unknown 25 mg Oral